curacle co., ltd. Logo

curacle co., ltd.

A clinical-stage biopharma developing drugs for intractable vascular diseases.

365270 | KO

Overview

Corporate Details

ISIN(s):
KR7365270008
LEI:
Country:
South Korea
Address:
서울특별시 서초구 효령로 23-1, 서울특별시

Description

Curacle Co., Ltd. is a clinical-stage biopharmaceutical company focused on the research and development of innovative drugs for intractable vascular diseases. The company's core platform technology centers on developing highly effective protectors against endothelial dysfunction, a key factor in various age-related and vascular conditions. Its development pipeline includes novel treatments targeting significant unmet medical needs, with a particular focus on conditions such as Diabetic Macular Edema (DME), Wet Age-related Macular Degeneration (wet AMD), diabetes, and stroke. Curacle aims to create differentiated therapies through innovative targets and treatment concepts, including the development of orally administered medications for complex eye diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-06-28 00:00
증권발행결과(자율공시)(제1회차 CB)
Korean 5.6 KB
2023-06-26 00:00
주요사항보고서(전환사채권발행결정)
Korean 72.8 KB
2023-06-23 00:00
투자판단관련주요경영사항(임상시험계획승인신청등결정)(중증도 내지 중증 궤양성 대장염에 대한 CU104 의 제2상 임상시험 계획 승인(IND))
Korean 11.3 KB
2023-06-05 00:00
기업설명회(IR)개최
Korean 6.8 KB
2023-05-22 00:00
투자판단관련주요경영사항(임상시험계획승인신청)(CU104의 제2상 임상시험계획승인신청(IND))
Korean 8.6 KB
2023-05-15 00:00
분기보고서 (2023.03)
Korean 665.0 KB
2023-03-30 00:00
정기주주총회결과
Korean 19.0 KB
2023-03-30 00:00
주식매수선택권부여에관한신고
Korean 12.3 KB
2023-03-22 00:00
감사보고서제출
Korean 18.8 KB
2023-03-22 00:00
사업보고서 (2022.12)
Korean 1.0 MB
2023-03-16 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 29.9 KB
2023-03-15 00:00
주주총회소집공고
Korean 123.7 KB
2023-03-15 00:00
주주총회소집결의
Korean 8.1 KB
2023-03-15 00:00
[기재정정]주주총회소집공고
Korean 125.4 KB
2023-03-15 00:00
주주총회집중일개최사유신고
Korean 5.5 KB

Automate Your Workflow. Get a real-time feed of all curacle co., ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for curacle co., ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for curacle co., ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.